Difference between revisions of "Finasteride"
Jump to navigation
Jump to search
m (Protected "Finasteride" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
|||
| Line 13: | Line 13: | ||
==Guidance== | ==Guidance== | ||
If less than four weeks since use, refer to MO. Inform transplant centre. | If less than four weeks since use, refer to MO. Inform transplant centre. | ||
| + | |||
| + | Donors are advised not to give blood for four weeks after taking Finasteride. This is to eliminate risk of exposure of a pregnant women to Finasteride through blood / blood product transfusion. In the setting of stem cell donation this is unlikely to be a concern, but TC should be informed if donor is taking Finasteride. | ||
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
Revision as of 12:41, 13 July 2016
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
Medication blocking the production of testosterone. Often used in treating disorders of the prostate.
Guidance
If less than four weeks since use, refer to MO. Inform transplant centre.
Donors are advised not to give blood for four weeks after taking Finasteride. This is to eliminate risk of exposure of a pregnant women to Finasteride through blood / blood product transfusion. In the setting of stem cell donation this is unlikely to be a concern, but TC should be informed if donor is taking Finasteride.
Pseudonyms or Related Conditions
Proscar
Version
Version 1, Edition 1
Date of Last Update
15th June 2012
